-
Real-world testing practices, treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer : a retrospective chart review study (REFLECT)Janžič, Urška, onkologinja ...The targeted therapy with tyrosine kinase inhibitors (TKIs) against the epidermal growth factor receptor mutation (EGFRm) in advanced non-small cell lung cancer (NSCLC) changed the treatment ... paradigm. REFLECT study (NCT04031898) explored EGFR/T790M testing and treatment patterns in EGFRm NSCLC patients receiving first- or second-generation (1G/2G) EGFR TKIs as front-line (1L) in eight countries. Pooled data from Central Eastern Europe (CEE) countries from this study (Bulgaria, Poland, Romania, Slovenia) are presented here. This physician-led chart review study was conducted in patients with confirmed-EGFRm NSCLC initiating 1L 1G/2G EGFR TKIs between 2015–2018. The CEE cohort included 389 patients receiving 1L erlotinib (37%), afatinib (34%), and gefitinib (29%). Overall, 320 (82%) patients discontinued 1L, and 298 (77%) progression events were registered. Median progression free survival on 1L TKIs was 14.0 (95% CI: 12.6–15.6) months. Median overall survival from 1L start was 26.6 (95% CI: 24.1–29.0) months. Attrition rate between 1L and next line was 30%. Among patients with 1L progression, 200 (67%) were tested for T790M and 58% were positive. This first CEE analysis of treatments and outcomes in EGFRm NSCLC patients highlights the importance of using the most efficacious therapies currently available in 1L to reduce attrition and improve patient outcomes.Source: Current oncology. - ISSN 1198-0052 (Vol. 29, iss. 8, Aug. 2022, str. 5833-5845)Type of material - article, component part ; adult, seriousPublish date - 2022Language - englishCOBISS.SI-ID - 119484931
Author
Janžič, Urška, onkologinja |
Turnšek, Nina, zdravnica |
Dediu, Mircea |
Shterev Donev, Ivan |
Lupu, Roxana |
Teodorescu, Gabriela |
Ciuleanu, Tudor |
Płużański, Adam
Topics
Pljučni rak |
Pljučne novotvorbe |
Nedrobnocelični karcinom pljuč |
Lung neoplasms |
Carcinoma, non-small cell lung |
Europe, Eastern |
Vzhodna Evropa |
klinične študije |
raziskava REFLECT |
receptor epidermalnega rastnega faktorja |
rak pljuč |
real-world study |
REFLECT study |
epidermal growth factor receptor |
lung cancer
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Janžič, Urška, onkologinja | 51382 |
Turnšek, Nina, zdravnica | 33928 |
Dediu, Mircea | |
Shterev Donev, Ivan | |
Lupu, Roxana | |
Teodorescu, Gabriela | |
Ciuleanu, Tudor | |
Płużański, Adam |
Select pickup location:
Material pickup by post
Notification
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.